Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 1;21(1):145-150.
doi: 10.4103/jcrt.jcrt_2405_23. Epub 2025 Apr 2.

Immunohistochemical expression of PDL1 and Ki67 in glioma and its correlation with treatment and overall survival

Vineet Kumar  1 , Shivanjali Raghuvanshi  1 , Shalini Bhalla  1 , Shalini Rawat  1 , Bal Krishna Ojha  2 , Chhitij Srivastava  2 , Madhu Mati Goel  3
Affiliations
Free article

Immunohistochemical expression of PDL1 and Ki67 in glioma and its correlation with treatment and overall survival

Vineet Kumar et al. J Cancer Res Ther. .
Free article

Abstract

Context: Gliomas are the most common primary brain tumors with an infiltrative nature; hence, complete removal is difficult, and despite radiotherapy and chemotherapy, there have been a high recurrence and poor survival rates. Hence, novel therapeutic strategies are needed to reduce recurrence and improve prognosis. Programmed death cell ligand (PD-L1) is a major prognostic biomarker for immune therapy in many cancers by using anti-PD-L1 antibodies. Studies have shown an upregulation in the PD-L1 and a therapeutic potential for improving survival. The current study was undertaken to evaluate immunohistochemical expression of PDL1 and Ki67 in gliomas and their correlation with clinicopathological parameters, prognostic and survival outcomes.

Methods and material: Histologically confirmed glioma cases were assessed for PD-L1 and Ki-67 immunohistochemical expression. Detailed clinicopathological study and prognostic outcomes were analyzed in these Glioma cases.

Results: Out of 65 glioma cases, 40 (61.5%) were found to be high-grade glioma and the rest 25 (38.5%) were low-grade glioma. Diffuse/fibrillary expression of PD-L1 was found in 60% of glioma cases. A low Ki67 proliferation index of ≤4% was observed in 27 cases (14.5%), with 5-10% expression in 12 (18.5%) and >10% expression in 26 cases (40.0%). The majority of the cases with <10% Ki67 expression had negative to low-grade PDL expression, while the majority with >10% Ki67 expression had moderate to strong PDL expression. This association was found to be significant statistically.

Conclusions: In the study, a statistically significant correlation between PD-L1 expression and tumor cell proliferation was observed with a histological grade. Association of survival rate was seen with the expression of the markers. However, studies with larger samples would be needed for confirmation.

PubMed Disclaimer

References

    1. Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol Mech Dis 2006;1:97–117.
    1. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-cell apoptosis:A potential mechanism of immune evasion. Nat Med 2002;8:793.
    1. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, et al. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity. Nat Med 2003;9:562.
    1. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365.
    1. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. Costimulatory B7-H1 in renal cell carcinoma patients:Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci 2004;101:17174–9.

MeSH terms

LinkOut - more resources